Trust Point’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$289K Buy
+1,500
New +$162K 0.02% 380
2024
Q3
– Sell
-1,853
Closed -$220K – 525
2024
Q2
$220K Buy
+1,853
New +$234K 0.02% 459

Other funds holding MRNA

Trust Point's MRNA Position: Q3 2026 in Review

Trust Point opened a new position in Moderna (MRNA) in Q3 2026: 1,500 shares worth $289K. The stake represents 0.02% of the portfolio and ranks #380 among its holdings. This is a return to the name: Trust Point previously reported a position in MRNA as recently as Q2 2024.

Trust Point first reported a position in MRNA in Q2 2024 and has held it in 2 quarters since. 858 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Trust Point held 1,500 shares of Moderna worth $289K as of Q3 2026.
  • Moderna was a new Trust Point position in Q3 2026.
  • Moderna made up 0.02% of Trust Point's portfolio in Q3 2026, its #380 holding.
  • Trust Point first reported a position in Moderna in Q2 2024 and has held it in 2 quarters since.
  • 858 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.